Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06414863 · ClinicalTrials.gov registry record · NA
Effects of Invisalign Palatal Expander System
A NA study of Palatal Expansion Technique, sponsored by University of the Pacific.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06414863: Recruiting NA study of Palatal Expansion Technique, sponsored by University of the Pacific.
NCT06414863 is a NA study of Palatal Expansion Technique that is actively recruiting participants, run by University of the Pacific. The registered enrollment target is 120 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06414863, a NA study of Palatal Expansion Technique, is actively recruiting participants, sponsored by University of the Pacific.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to evaluate the effectiveness of Invisalign Palatal Expander system ingrowing patients. This study compares the treatment outcomes of Invisalign Palatal Expander system to conventional treatments through randomized controlled trial.
Primary Outcome
Transverse changes on CBCTs
Conditions Studied
Interventions
- DEVICE IPE
- DEVICE HE
Study Locations (1)
California
- University of the Pacific - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-05-10 |
| Est. Completion | 2034-05-10 |
| Phase | NA |
What NCT06414863 shows while recruiting
NCT06414863 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Palatal Expansion Technique appearing as the primary indexed condition, and to 2 interventions - of which IPE is the first listed.
NCT06414863 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06414863 about?
NCT06414863 is a clinical study titled "Effects of Invisalign Palatal Expander System". The aim of this study is to evaluate the effectiveness of Invisalign Palatal Expander system ingrowing patients. This study compares the treatment outcomes of Invisalign Palatal Expander system to conventional treatments through randomized controlled trial.
What is the current status of trial NCT06414863?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2024-05-10. Estimated completion is 2034-05-10.
What conditions does trial NCT06414863 study?
This clinical trial studies the following conditions: Palatal Expansion Technique.
What interventions are being tested in trial NCT06414863?
The interventions under investigation include: IPE (DEVICE), HE (DEVICE).
Who is sponsoring clinical trial NCT06414863?
This trial is sponsored by University of the Pacific, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06414863 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06414863's enrollment target sits among peer trials
120 762nd of 2000 higher than 1,198 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI